1. Evaluate patient intent to receive and uptake of in-hospital post-partum highly effective, reversible contraception (LARC) including the Mirena, Paragard, and Nexplanon regardless of ability to pay
2. Evaluate satisfaction with with in hospital placement of Nexplanon or IUD following delivery.
3. Determine the continuation rate for long acting reversible contraceptives at 3, 6, 9, 12, and 18 months following in-hospital placement.
4. Evaluate expulsion rate and need for ultrasound to located IUDs placed immediately following delivery of the placenta on L&D.